||WO||WO/2014/170886 - SYSTEM AND METHOD FOR ONLINE PROCESSING OF VIDEO IMAGES IN REAL TIME||23.10.2014||
||PCT/IL2013/050485||DIGITAL MAKEUP LTD||GUISSIN, Rami|
The invention is directed to real-time processing of video data. In some examples at least one image of the video data is processed utilizing reference data comprising reference image data of background within a region of interest and clutter image data indicative thereof, to determine a pixel deviation level of each pixel in the at least one image and generate pixel-deviation image data indicative thereof. The pixel- deviation image data is processed to enhance its tonal pixel distribution and generating enhanced image data, which is processed to determine a threshold level based on the tonal pixel distribution. A binary image map is then generated using the determined threshold level, the binary image map being indicative of the background and foreground components of the at least one image.
||WO||WO/2014/170898 - NON-IMMUNOGENIC AND NUCLEASE RESISTANT NUCLEIC ACID ORIGAMI DEVICES AND COMPOSITIONS THEREOF||23.10.2014||
||PCT/IL2014/050356||BAR-ILAN UNIVERSITY||BACHELET, Ido|
Nucleic acid origami devices are provided that are non-immunogenic and/or resistant to nucleases, which may be activated by one or more external cues, such as ligands, glucose concentration or electromagnetic fields; or used for attenuation or prevention of internalization of cell-surface receptors or prolongation of shelf-life of active agents. Further provided are methods for treating diabetes and methods for preparing the devices.
||WO||WO/2014/170890 - FOSSA OVALIS PENETRATION APPARATUS||23.10.2014||
||PCT/IL2014/050338||TRANSSEPTAL SOLUTIONS LTD.||MAISANO, Francesco|
Apparatus and methods are described, including apparatus (34) for puncturing a fossa ovalis (18) of a heart (22). The apparatus (34) comprises a catheter (38) shaped to define a catheter lumen (52). A puncturing element (32) is slidably disposed within the catheter lumen (52), and is configured to be deployed from a distal portion of the catheter (38) and to puncture the fossa ovalis (18). One or more flexible longitudinal members (14) are configured to be deployed from the distal portion (54) of the catheter (38), and upon being deployed, facilitate the puncturing of the fossa ovalis (18) by the puncturing element (32), by contacting tissue at a perimeter (60) of the fossa ovalis (18). Other applications are also described.
||WO||WO/2014/170891 - AN ENERGY CONVERSION DEVICE DRIVEN BY WIND POWER||23.10.2014||
||PCT/IL2014/050339||PEKELIS, Anatoli||PEKELIS, Anatoli|
The invention is an energy conversion device driven by wind power, comprising a housing to protect the working components of the device from environmental damage and to insure correct flow of air through the device, at least one directing element, connected to the housing, air exit and entrance openings, one or more separating surfaces inside the housing, inside components forming a carousel, a frame structure surrounding the components inside the housing, set of sails, wherein each sail is comprised of a pair of blades connected by a hinge-like structure, wherein the free end of one of said blades is connected to said separating surface by a rail and the free end of the other of said blades is connected to a fixed point on said frame structure, a transmission system and lifting means for adjustment of the height of the structure above the ground or water.
||WO||WO/2014/170893 - OIL CARRYING PARTICULATE MATTER AND USES THEREOF||23.10.2014||
||PCT/IL2014/050346||NOBACTRA ISRAEL LTD.||KRITZMAN, Giora|
The present disclosure provides a particulate matter comprising particles carrying an essentially dry combination of components comprising at least one natural oil and at least one surfactant, the components being selected such that upon contact with water, oil in water emulsion is formed. In particular, the emulsion formed is a stable emulsion, with stability of at least several hours, as observed by the lack of phase separation during that time.
||WO||WO/2014/170894 - A PACKAGE FOR PLANT ANTIMICROBIAL TREATMENT||23.10.2014||
||PCT/IL2014/050348||NOBACTRA ISRAEL LTD.||KRITZMAN, Giora|
The present invention provides a package (200) comprising at least one first component in the form a well (220), the first component comprising particulate matter comprising at least one natural oil; at least one second component, in the form of a plurality of second wells (230) comprising antagonist(s) of a microbial pathogen; wherein the at least one first component and the at least one second component are contained in separate compartments of said package. Also provided by the present invention is a method for providing an anti- bacterial agent, the method comprising mixing the first component comprising particulate matter carrying at least one natural oil; and at least one second component comprising at least one antagonist of a microbial pathogen, and allowing said mixture to form into an emulsion with anti-bacterial activity. Further provided by the present invention is a method of treating or preventing a pathogen infection in a plant, the method comprises applying to said plant an amount of an emulsion comprising particulate matter, at least one natural oil and at least one antagonist of a microbial pathogen that causes said pathogen infection. Yet further, there are provided some isolated antagonistic bacteria that may be used, inter alia, in the package and methods disclosed herein.
||WO||WO/2014/170897 - CLASSIFYING EEG SIGNALS IN RESPONSE TO VISUAL STIMULUS||23.10.2014||
||PCT/IL2014/050355||YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.||DEOUELL, Leon|
Systems and method for conduction of single trial classification of EEG signals of a human subject generated responsive to a series of images containing target images and non-target images, the method comprising: obtaining said EEG signals in a spatio-temporal representation comprising time points and respective spatial distribution of said EEG signals; classifying said time points independently, using a linear discriminant classifier, to compute spatio-temporal discriminating weights; using said spatio-temporal discriminating weights to amplify said spatio-temporal representation by said spatio-temporal discriminating weights at tempo-spatial points respectively, to create a spatially-weighted representation; using Principal Component Analysis (PCA) on a temporal domain for dimensionality reduction, separately for each spatial channel of said EEG signals, to create a PCA projection; applying said PCA projection to said spatially-weighted representation onto a first plurality of principal components, to create a temporally approximated spatially weighted representation containing for each spatial channel, PCA coefficients for said plurality of principal temporal projections; and classifying said temporally approximated spatially weighted representation, over said number of channels, using said linear discriminant classifier, to yield a binary decisions series indicative of each image of the images series as either belonging to said target image or to said non-target image.
||WO||WO/2014/170899 - SYSTEMS COMPRISING NON-IMMUNOGENIC AND NUCLEASE RESISTANT NUCLEIC ACID ORIGAMI DEVICES FOR MOLECULAR COMPUTATION||23.10.2014||
||PCT/IL2014/050357||BAR-ILAN UNIVERSITY||BACHELET, Ido|
Systems acting as logic gates and systems exhibiting quorum sensing are provided, wherein said systems comprise at least one effector nucleic acid origami device, at least one regulator nucleic acid origami device, at least one input and at least one output, and the nucleic acid origami devices are non-immunogenic and/or resistant to nucleases.
||WO||WO/2014/170900 - INHIBITORS OF THE Eph-A RECEPTOR AND USES THEREOF||23.10.2014||
||PCT/IL2014/050359||UNIVERSITY OF HAIFA||LEMPRECHT, Raphael|
Eph A receptor inhibitor peptides, and particularly Eph A4 receptor inhibitor peptides, are provided. The peptides comprise a sequence derived from the G-H loop of ephrin A4. Further, pharmaceutical compositions comprising said peptides and use thereof in treating, ameliorating or preventing diseases associated with memory formation are provided.
||WO||WO/2014/170888 - DRUG CONTAINER CLOSURE FOR MOUNTING ON OPEN-TOPPED DRUG CONTAINER TO FORM DRUG RECONSTITUTION ASSEMBLAGE FOR USE WITH NEEDLELESS SYRINGE||23.10.2014||
||PCT/IL2014/050327||MEDIMOP MEDICAL PROJECTS LTD||LEV, Nimrod|
A drug container closure for mounting on an open-topped drug container to form a ready-to-use drug reconstitution assemblage for use with a needleless syringe. The drug container closure includes a drug container stopper for sealing the drug container and a fluid transfer member with an integral needleless syringe connector and a puncturing cannula. The fluid transfer member is manually disposed along a diametric inverted L-shaped track pair from an initial non-puncturing position to a puncturing position. The inverted L-shaped track pair includes one-way snap members to prevent a user returning the fluid transfer member to an earlier position and indicating progress of the user activation.